News
Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...
Rosa Tellez-Moore finds hope and healing through groundbreaking research at UC San Diego Health Rosa Tellez-Moore is grateful ...
Ampreloxetine is being developed to address the root cause of blood pressure instability in multiple system atrophy, aiming ...
This year a clinical trial will test a drug combination designed to bring lasting relief for people with panic disorder – a ...
14h
ScienceAlert on MSNNew Weight Loss Drug Outperformed Existing Treatment in Clinical Trial
Like semaglutide, the new drug known as ecnoglutide is glucagon-like peptide-1 receptor agonist. In simple terms, they both ...
EmVenio Clinical Research expands global trial access with brand consolidation and launches Patient Navigatorâ„¢ to improve access for trial participants.
14h
TipRanks on MSNSona Nanotech Advances Clinical Trial for Innovative Cancer Therapy
Sona Nanotech Inc ( ($TSE:SONA) ) has shared an announcement. Sona Nanotech Inc. has provided an update on its first-in-human clinical trial for ...
Indian biotech & pharma sectors adopt virtual transformation as cloud-powered trials redefine clinical research: Nandita Vijayasimha, Bengaluru Tuesday, August 26, 2025, 08:00 Hrs ...
Innovent's bispecific antibody, IBI363, enters a global phase 3 trial for IO-resistant lung cancer, the first of its kind, ...
The FDA will now publish adverse event data from FAERS on a daily basis, marking a major step toward greater transparency in drug development.
To find out how FDA’s new draft guidance, Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical ...
Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies based on its uniquely biocompatible gold nanorod ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results